| Dr Shixiong Liao, MD | |
|
283 Dorchester Manor Blvd, N Charleston, SC 29420-8108 | |
| (843) 300-3001 | |
| (843) 300-3003 |
| Full Name | Dr Shixiong Liao |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 37 Years |
| Location | 283 Dorchester Manor Blvd, N Charleston, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285698829 | NPI | - | NPPES |
| 24005 | Other | SC | SC MEDICAL LICENSE# |
| T80141 | Medicaid | SC | |
| 2012-02070 | Other | NC | MEDICAL LICENSE |
| 70136 | Other | GA | MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 24005 (South Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carolina Digestive Disease Pa | 3375714769 | 4 |
News Archive
Caspase-12 is a molecule with a death-wish. Found only in people of African descent, this protein shuts down our body's immune system, opening the door to potentially lethal infections. In a groundbreaking new study published in the prestigious journal Nature this week, the team that first discovered the role of caspase-12 in humans has now uncovered the mechanism by which it sabotages us, allowing researchers to develop methods to counter its damaging effects.
Qosina now stocks SMC series polycarbonate non-luer connectors from Colder Products CompanyÒ. The SMC is a twist-to-connect coupling that provides a reliable and more secure alternative to traditional luer-type connections and will not mate to a standard luer.
Working to expand access of state-of-the-art medical imaging to underdeveloped regions around the world, GE Global Research, the technology development arm for the General Electric Company, has been awarded a four-year, $3.27 million award from National Institutes of Health (NIH) to develop new magnet technology that will make MRI systems less costly and easier to site.
In its November meeting, the Pharmaceutical Benefits Advisory Committee (PBAC) will consider Novo Nordisk's second-to-market glucagon-like peptide-1 (GLP-1) agonist Victoza for reimbursement, which would be essential in order for the drug to compete effectively with Eli Lilly's Byetta. However, its chances of success are uncertain, considering that it took three years to get Byetta on the Pharmaceutical Benefits Scheme (PBS).
› Verified 1 days ago
| Entity Name | Columbia Gastroenterology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922080266 PECOS PAC ID: 9234035759 Enrollment ID: O20040526001352 |
News Archive
Caspase-12 is a molecule with a death-wish. Found only in people of African descent, this protein shuts down our body's immune system, opening the door to potentially lethal infections. In a groundbreaking new study published in the prestigious journal Nature this week, the team that first discovered the role of caspase-12 in humans has now uncovered the mechanism by which it sabotages us, allowing researchers to develop methods to counter its damaging effects.
Qosina now stocks SMC series polycarbonate non-luer connectors from Colder Products CompanyÒ. The SMC is a twist-to-connect coupling that provides a reliable and more secure alternative to traditional luer-type connections and will not mate to a standard luer.
Working to expand access of state-of-the-art medical imaging to underdeveloped regions around the world, GE Global Research, the technology development arm for the General Electric Company, has been awarded a four-year, $3.27 million award from National Institutes of Health (NIH) to develop new magnet technology that will make MRI systems less costly and easier to site.
In its November meeting, the Pharmaceutical Benefits Advisory Committee (PBAC) will consider Novo Nordisk's second-to-market glucagon-like peptide-1 (GLP-1) agonist Victoza for reimbursement, which would be essential in order for the drug to compete effectively with Eli Lilly's Byetta. However, its chances of success are uncertain, considering that it took three years to get Byetta on the Pharmaceutical Benefits Scheme (PBS).
› Verified 1 days ago
| Entity Name | Lowcountry Gastroenterology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154437291 PECOS PAC ID: 1850350802 Enrollment ID: O20041006000650 |
News Archive
Caspase-12 is a molecule with a death-wish. Found only in people of African descent, this protein shuts down our body's immune system, opening the door to potentially lethal infections. In a groundbreaking new study published in the prestigious journal Nature this week, the team that first discovered the role of caspase-12 in humans has now uncovered the mechanism by which it sabotages us, allowing researchers to develop methods to counter its damaging effects.
Qosina now stocks SMC series polycarbonate non-luer connectors from Colder Products CompanyÒ. The SMC is a twist-to-connect coupling that provides a reliable and more secure alternative to traditional luer-type connections and will not mate to a standard luer.
Working to expand access of state-of-the-art medical imaging to underdeveloped regions around the world, GE Global Research, the technology development arm for the General Electric Company, has been awarded a four-year, $3.27 million award from National Institutes of Health (NIH) to develop new magnet technology that will make MRI systems less costly and easier to site.
In its November meeting, the Pharmaceutical Benefits Advisory Committee (PBAC) will consider Novo Nordisk's second-to-market glucagon-like peptide-1 (GLP-1) agonist Victoza for reimbursement, which would be essential in order for the drug to compete effectively with Eli Lilly's Byetta. However, its chances of success are uncertain, considering that it took three years to get Byetta on the Pharmaceutical Benefits Scheme (PBS).
› Verified 1 days ago
| Entity Name | Kassamo Dayemo Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578723037 PECOS PAC ID: 0749351468 Enrollment ID: O20080624000092 |
News Archive
Caspase-12 is a molecule with a death-wish. Found only in people of African descent, this protein shuts down our body's immune system, opening the door to potentially lethal infections. In a groundbreaking new study published in the prestigious journal Nature this week, the team that first discovered the role of caspase-12 in humans has now uncovered the mechanism by which it sabotages us, allowing researchers to develop methods to counter its damaging effects.
Qosina now stocks SMC series polycarbonate non-luer connectors from Colder Products CompanyÒ. The SMC is a twist-to-connect coupling that provides a reliable and more secure alternative to traditional luer-type connections and will not mate to a standard luer.
Working to expand access of state-of-the-art medical imaging to underdeveloped regions around the world, GE Global Research, the technology development arm for the General Electric Company, has been awarded a four-year, $3.27 million award from National Institutes of Health (NIH) to develop new magnet technology that will make MRI systems less costly and easier to site.
In its November meeting, the Pharmaceutical Benefits Advisory Committee (PBAC) will consider Novo Nordisk's second-to-market glucagon-like peptide-1 (GLP-1) agonist Victoza for reimbursement, which would be essential in order for the drug to compete effectively with Eli Lilly's Byetta. However, its chances of success are uncertain, considering that it took three years to get Byetta on the Pharmaceutical Benefits Scheme (PBS).
› Verified 1 days ago
| Entity Name | Carolina Digestive Disease Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285929794 PECOS PAC ID: 3375714769 Enrollment ID: O20110914000829 |
News Archive
Caspase-12 is a molecule with a death-wish. Found only in people of African descent, this protein shuts down our body's immune system, opening the door to potentially lethal infections. In a groundbreaking new study published in the prestigious journal Nature this week, the team that first discovered the role of caspase-12 in humans has now uncovered the mechanism by which it sabotages us, allowing researchers to develop methods to counter its damaging effects.
Qosina now stocks SMC series polycarbonate non-luer connectors from Colder Products CompanyÒ. The SMC is a twist-to-connect coupling that provides a reliable and more secure alternative to traditional luer-type connections and will not mate to a standard luer.
Working to expand access of state-of-the-art medical imaging to underdeveloped regions around the world, GE Global Research, the technology development arm for the General Electric Company, has been awarded a four-year, $3.27 million award from National Institutes of Health (NIH) to develop new magnet technology that will make MRI systems less costly and easier to site.
In its November meeting, the Pharmaceutical Benefits Advisory Committee (PBAC) will consider Novo Nordisk's second-to-market glucagon-like peptide-1 (GLP-1) agonist Victoza for reimbursement, which would be essential in order for the drug to compete effectively with Eli Lilly's Byetta. However, its chances of success are uncertain, considering that it took three years to get Byetta on the Pharmaceutical Benefits Scheme (PBS).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shixiong Liao, MD 1800 S Hawthorne Rd, Winston Salem, NC 27103-4014 Ph: (336) 999-8888 | Dr Shixiong Liao, MD 283 Dorchester Manor Blvd, N Charleston, SC 29420-8108 Ph: (843) 300-3001 |
News Archive
Caspase-12 is a molecule with a death-wish. Found only in people of African descent, this protein shuts down our body's immune system, opening the door to potentially lethal infections. In a groundbreaking new study published in the prestigious journal Nature this week, the team that first discovered the role of caspase-12 in humans has now uncovered the mechanism by which it sabotages us, allowing researchers to develop methods to counter its damaging effects.
Qosina now stocks SMC series polycarbonate non-luer connectors from Colder Products CompanyÒ. The SMC is a twist-to-connect coupling that provides a reliable and more secure alternative to traditional luer-type connections and will not mate to a standard luer.
Working to expand access of state-of-the-art medical imaging to underdeveloped regions around the world, GE Global Research, the technology development arm for the General Electric Company, has been awarded a four-year, $3.27 million award from National Institutes of Health (NIH) to develop new magnet technology that will make MRI systems less costly and easier to site.
In its November meeting, the Pharmaceutical Benefits Advisory Committee (PBAC) will consider Novo Nordisk's second-to-market glucagon-like peptide-1 (GLP-1) agonist Victoza for reimbursement, which would be essential in order for the drug to compete effectively with Eli Lilly's Byetta. However, its chances of success are uncertain, considering that it took three years to get Byetta on the Pharmaceutical Benefits Scheme (PBS).
› Verified 1 days ago
Karl K. Gruber, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 9330 Medical Plaza Dr, N Charleston, SC 29406 Phone: 843-797-4179 Fax: 843-797-4296 | |
Dr. Danyel Bourgeois Mcevoy, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 4450 Leeds Pl W Ste A, N Charleston, SC 29405 Phone: 843-763-2611 Fax: 843-852-4099 | |
Charles J. Geilfuss Iii, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 9330 Medical Plaza Dr, N Charleston, SC 29406 Phone: 843-847-4179 Fax: 843-847-4296 |